Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byShire
Price$160M
Date3/2013
TermsCash

General Information

Offices

Brisbane, USA
1000 Marina Blvd.
Suite 250
Brisbane, CA, 94005
USA

People

Chief Executive Officer
Chief Financial Officer
Board Member
Board of Directors
Board of Directors
Board of Directors
Board of Directors
General Counsel

Funding

TOTAL $73M
FUNDING TOTAL $73M
Venture Round, 12/2006
Alta Partners
Clarus Ventures
$29M
Series B, 7/2011
Sofinnova Ventures
Rho Capital Partners
Alta Partners
Clarus Ventures
$44M

Tags

SARcode Bioscience

SARcode Corporation is a private San Francisco based biopharmaceutical company engaged in the development of a novel class of small molecule lymphocyte function-associated antigen-1 (LFA-1; CD11a/CD18; αLβ2) antagonists as a topical agent for the treatment of significant unmet medical needs in ophthalmology, dermatology and other inflammatory diseases.

Recent Milestones

Videos

Screenshots

SARcode Bioscience screenshot
Above: SARcode Corporation
Uploaded: 4/21/10

Sources

  1. Shire to Acquire Dry-Eye Drug Developer SARcode Bioscience (pevc.dowjones.com) [edit]
  2. SARcode secured $25 million in financing (sarcode.com) [edit]
  3. SARcode Bioscience Closes $44M Series B Financing (finsmes.com) [edit]
Edit This Page
Last Edited 9/27/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy